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At the frontline — Research
ness, especially in the first 2 years of life, is
recognised as an important predeterminant
of adult lung disease.3,4 Studies in Central
Australia have shown a  increased risk of
chronic respiratory conditions, such as
bronchiectasis, in Indigenous children,
probably as a result of repeated respiratory
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Objective: To describe the epidemiology of acute lower respiratory infection (ALRI) and 
bronchiectasis in Northern Territory Indigenous infants hospitalised in the first year of life.
Design: A historical cohort study constructed from the NT Hospital Discharge Dataset 
and the NT Immunisation Register.
Participants and setting: All NT resident Indigenous infants, born 1 January 1999 to 
cember 2004, admitted to NT public hospitals and followed up to 12 months of age.
 outcome measures:  Incidence of ALRI and bronchiectasis (ICD-10-AM codes) 
adiologically confirmed pneumonia (World Health Organization protocol).
lts: Data on 9295 infants, 8498 child-years of observation and 15 948 hospitalised 
des of care were analysed. ALRI incidence was 426.7 episodes per 1000 child-years 
 CI, 416.2–437.2). Incidence rates were two times higher (relative risk, 2.12; 95% CI, 
1.98–2.27) for infants in Central Australia compared with those in the Top End. The 
median age at first admission for an ALRI was 4.6 months (interquartile range, 2.6–7.3). 
Bronchiolitis accounted for most of the disease burden, with a rate of 227 per 1000 child-
years. The incidence of first diagnosis of bronchiectasis was 1.18 per 1000 child-years 
(95% CI, 0.60–2.16). One or more key comorbidities were present in 1445 of the 3227 
(44.8%) episodes of care for ALRI.
Conclusions: Rates of ALRI and bronchiectasis in NT Indigenous infants are excessive, 
with early onset, frequent repeat episodes, and a high prevalence of comorbidities. 
MJA 2010; 192: 586–590
These high rates of disease demand urgent attention.
See also page 592ate
tio
to R s of acute lower respiratory infec-n (ALRI) are generally consideredreflect the ongoing and substantial
health disparities between Indigenous and
non-Indigenous children in Australia1 and
other affluent countries such as the United
States.2 Increasingly, early respiratory ill-
infection in infancy.5,6
However, available data on the epidemiology
of ALRI in Australian Indigenous infants are
limited. Importantly, there are no comprehen-
sive population data with standardised meth-
ods of defining pneumonia (World Health
Organization [WHO] radiologically defined
pneumonia) for comparison with those from
other countries. There are also no data compar-
ing ALRI rates in the Top End of the Northern
Territory and in Central Australia.
The morbidity of ALRI in NT Indigenous
children has recently been analysed in a large
study of pneumonia applying the WHO diag-
nostic protocol.7 Here, we report on a nested
analysis within that study describing the epi-
demiology of ALRI in NT Indigenous children
hospitalised in the first year of life.
METHODS
Design
We conducted a historical cohort study of
hospitalised episodes of ALRI in NT Indigen-
ous children aged less than 12 months. We
included all children born 1 January 1999 to
31 December 2004. Birth cohorts were con-
structed from two population-based health
datasets — the NT Immunisation Register
and the NT Hospital Discharge Dataset.
Setting
Five public hospitals in the NT admit all NT
Indigenous children requiring hospital treat-
ment.
Every child born in the NT or receiving
services at any public NT health service is
allocated a unique health record number.
This is used for all subsequent episodes of
medical care, and is also the basis for inclu-
sion on the NT Immunisation Register — a
population-based register that vaccine pro-
viders report to routinely. Children not born
in a public hospital are added to the immu-
nisation register either through compulsory
registration on the NT Midwives’ Collection,
or at the time of their first immunisation or
first presentation for health care.
Population studied
Children were included if they were born
between the specified dates and were resi-
dent in the NT at the time they were
registered. Person-time under observation
commenced at birth and ceased on 31
December 2004, or the date of the child’s
death, or the date the child turned 12
months of age, whichever occurred first.
Outcomes
All primary and secondary diagnoses within
an admission were included in the analysis.
Respiratory diagnoses
A diagnosis of an ALRI was based on an
ICD-10-AM code (International classifica-
tion of diseases, 10th revision, Australian
modification) within the range J10–J22
inclusive. Bronchiectasis was defined by
ICD-10-AM code J47.
Radiologically confirmed pneumonia
All chest x-rays taken within any admission
for any diagnosis were obtained from all
hospital radiology departments across the
NT. Films were read for WHO-defined
pneumonia.8 According to the WHO proto-
col, x-ray films are read independently by
two paediatric or respiratory physicians
blinded to all data on the demographic,
clinical and vaccination history of the sub-
ject. For admissions in which more than one
x-ray was taken, any film deemed positive
classified the admission episode as pneu-
monia. A positive first x-ray taken within 3
days of admission classified the admission
episode as community-acquired pneumonia.
Covariates
Data on respiratory diagnoses were exam-
ined by the infant’s age in months, sex,
region of residence in the NT, and any key
comorbidities present. Region of residenceMJA • Volume 192 Number 10 • 17 May 2010
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NT) or “Centre” (Central Australian region
of the NT). Key comorbidities were defined
as concomitant diagnoses of acute gastroen-
teritis, anaemia and malnutrition, classified
by groupings of multiple ICD-10-AM codes
for each category. Data on birthweight and
other potentially important characteristics
(eg, exposure to tobacco smoke) were not
available in the dataset.
Statistical analyses
Incidence rates were calculated by dividing
the number of cases by the person-time at
risk from birth and are presented in units
per 1000 child-years, with corresponding
95% confidence intervals. Relative risks and
their exact 95% CIs were calculated to com-
pare incidence rates by region and sex. The
Kruskal–Wallis rank test was used to com-
pare non-parametric distributions. Data
were analysed using Stata, version 10.1
(StataCorp, College Station, Tex, USA).
Ethics approval
The study was approved by the joint institu-
tional Human Research Ethics Committee of
the NT Department of Health and Com-
munity Services and the Menzies School of
Health Research (HREC ID: 05/49), and the
Human Research Ethics Committee of Cen-
tral Australia.
RESULTS
Overall episodes of care
There were 9295 infants, 8498 child-years
of observation and 15 948 hospitalised epi-
sodes of care over the study period; 8153
episodes of care were childbirth, and 747
(8.0%) infants had no record of having been
in hospital. Seventy-one per cent of infants
were Top End residents, 61% were from
remote areas, and 52% were boys.
There was a median of two diagnoses per
hospitalisation (range 1–40; interquartile
range [IQR], 1–3); 10% of episodes had five
or more diagnoses. Chest x-rays were
obtained in 88% of all episodes with a
diagnosis of ALRI.
There were 113 deaths recorded — an
overall infant mortality rate of 13.3 deaths
per 1000 child-years. Ninety-four deaths
(83.1%) occurred within 24 hours of birth,
two at 12 and 16 days of age, and 17
between 50 and 295 days of age. In 11 of
the 17 deaths after the perinatal period, the
child had a respiratory diagnosis (acute
bronchiolitis in four infants and pneumonia
unspecified in three).
Acute lower respiratory tract infections
There were 3227 (20%) episodes of care for
ALRI, and 3626 diagnoses of ALRI for 2028
infants (21.8%); 665 (7.2%) had two or
more episodes, and 55 (0.6%) had five or
more. The incidence was 426.7 episodes per
1000 child-years (95% CI, 416.2–437.2).
Incidence rates were 23% higher in boys
(relative risk [RR], 1.23; 95% CI, 1.15–
1.33) and over two times higher (RR, 2.12;
95% CI, 1.98–2.27) for infants in the Cen-
tral Australian region of NT.
The median age at the time of first admis-
sion for ALRI was 4.6 months (IQR, 2.6–
7.3) (Box 1). For children with multiple
episodes, the median intervals between first
to second, second to third, and third to
fourth episodes were 54, 62 and 45 days,
respectively. Intervals narrowed to medians
of 26–33 days for subsequent episodes.
There were clear differences in temporal
trends of ALRI diagnoses by NT region (Box
2). The associated diagnoses were dominated
by seasonal peaks for bronchiolitis in the first
quarter of the year in the Top End and in the
third quarter of the year in the Central Aus-
tralian region. Influenza outbreaks accounted
for peaks apparent in the fourth quarter of
2000 and third quarter of 2003 in both
2 Hospitalised episodes of acute lower respiratory infection (ALRI) and 
radiologically confirmed pneumonia in Northern Territory Indigenous children 
aged < 12 months, by time period and NT region
0
30
60
90
120
150
Centre: radiologically conﬁrmed pneumonia
Centre: all ALRI
Top End: radiologically conﬁrmed pneumonia
Top End: all ALRI
Q4Q3Q2Q1Q4Q3Q2Q1Q4Q3Q2Q1Q4Q3Q2Q1Q4Q3Q2Q1Q4Q3
1999 2000 2001
Year and quarter
N
um
b
er
 o
f c
as
es
2002 2003 2004
Q2Q1
1 Frequency distribution (%) of the first episode of acute lower respiratory 
infection (ALRI) requiring hospitalisation in Northern Territory Indigenous 
children aged < 12 months, by age in months and NT region
Age in months
Fi
rs
t 
ho
sp
ita
lis
ed
 e
p
is
o
d
e 
o
f A
LR
I 
0
3%
6%
9%
12%
15% Centre Top End
11109876543210MJA • Volume 192 Number 10 • 17 May 2010 587
AT TH E FRONTLINE —  RESEARCHregions. Seasonality was less clear for radio-
logically confirmed pneumonia.
One or more key comorbidities were
present in 1445 (44.8%) of the 3227 episodes
of care for ALRI: gastroenteritis in 832
(25.8%), anaemia in 896 (27.8%) and malnu-
trition in 128 (4.0%) episodes. Comorbidities
were more frequent in ALRI episodes than in
non-ALRI episodes and in pneumonia epi-
sodes than in bronchiolitis episodes (Box 3).
ALRI diagnostic groups
Of the ALRI diagnostic groups, bronchiolitis
was the most common; rates of 352 per
1000 child-years (95% CI, 333–371) in the
Central Australian region were double those
of the Top End (RR, 1.99; 95% CI, 1.82–
2.18). Discharge diagnoses in the 3227 epi-
sodes of care for ALRI and rates per 1000
child-years by diagnosis and NT region are
presented in Box 4.
There were 428 (13.3%) episodes of care
in 366 infants with radiologically confirmed
pneumonia diagnosed within 3 days of
admission. In a total of 457 (14.2%) epi-
sodes of care for ALRI, pneumonia was
confirmed radiologically; 249 of these
(54.5%) were unspecified pneumonias, and
160 (35.0%) were bronchiolitis.
Three hundred and seventeen infants had
one episode and 49 had two or more epi-
sodes of radiologically confirmed pneu-
monia before 12 months of age. The overall
incidence was 43.7 episodes per 1000 child-
years (95% CI, 39.5–48.3): 38.3 (95% CI,
33.6–43.5) in infants in the Top End and
78.4 (95% CI, 68.1–89.6) in Central Aus-
tralian infants. The median age at the time of
the first episode was 5.7 months (IQR, 1.4–
8.6 months). Of the 366 infants with one or
more episodes of radiologically confirmed
pneumonia, 101 (27.6%) had had at least
one prior hospitalisation for ALRI before the
first pneumonia episode.
Bronchiectasis
There were 13 episodes of care for 10 infants
with bronchiectasis — an incidence of 1.18
per 1000 child-years (95% CI, 0.60–2.16).
The incidence in Central Australian infants
was 2 per 1000 child-years compared with
0.8 per 1000 child-years in Top End infants
(RR, 2.4; 95% CI, 0.72–7.97); seven were
boys. The median age at admission for the
first diagnosis was 8.5 months (IQR, 4.1–
10.2 months). All infants had multiple
comorbidities at each admission; two had a
concomitant diagnosis of radiologically con-
firmed pneumonia.
For four infants, the first episode of bron-
chiectasis was the first episode of care for a
respiratory illness; the remaining infants had
had between one and three prior hospital-
ised episodes with an ALRI. Three infants
had had two prior episodes of radiologically
confirmed pneumonia; for each child there
was a 2-month interval between each epi-
sode of radiologically confirmed pneumonia
and a 2-month interval until the subsequent
episode for bronchiectasis.
DISCUSSION
One in five NT Indigenous infants will be
hospitalised at least once before their first
birthday with an ALRI; 7% will have two or
more episodes and 4% will have radiolo-
gically confirmed lobar pneumonia. The
first hospitalised episode occurs early in life,
with 50% of cases occurring before 5
months of age; in 45% of episodes one or
more comorbidities — anaemia, gastroen-
teritis, malnutrition — are present. At least
one in every thousand NT Indigenous
infants has bronchiectasis in their first year
of life. The risk for most respiratory diag-
noses is twice as high for infants in the
Central Australian region of NT as it is for
those in the Top End.
The rates of hospitalisation for ALRI (427
per 1000 child-years) among NT Indigenous
infants are substantially higher than those in
American Indian or Alaskan Native infants
(116 per 1000 child-years),9 or those in
developing countries (290 episodes per 1000
child-years in children aged < 5 years),10 as
described in a meta-analysis of community-
based studies. The incidence of WHO-
defined radiologically confirmed pneumonia
among children in the Central Australian
region of NT (78.4 episodes per 1000 child-
years; 95% CI, 68.1–89.6) is the highest
incidence reported in published studies
using the WHO protocol. These include
studies of infants in the US,11 The Gambia,12
South Africa,13 Fiji,14 Uruguay,15 Indone-
sia,16 the Philippines,17 and Pakistan.18 Dif-
ferences in case-ascertainment methods and
access to hospital may partly explain the
high rates we observed; however, they can-
not entirely explain our findings.
Our study has identified a marked
increase in hospital admissions for bronchi-
olitis (all causes) in infants. Between 1998
and 2000, the incidence in Central Australia
was 190 per 1000 population aged under 12
months (88% were Aboriginal infants),19
compared with 352 per 1000 child-years in
our study. Both studies reviewed all hospi-
talisations and included both primary and
secondary diagnoses; however, the former
study included the use of ICD-9-CM diag-
noses, and incidence was calculated based
on 1999 population data.19 A clear annual
increase since 1999 was observed in our
study, with a large epidemic in 2004. Hos-
pitalisations for bronchiolitis have also been
increasing in Western Australian Aboriginal
infants,20 as well as in the American Indian
population,9 for reasons that are not clear.
The high proportion of radiologically con-
firmed pneumonia in bronchiolitis episodes
is consistent with emerging evidence that
3 Number (%)* of episodes of care in hospital for acute lower respiratory infection (ALRI) with one or more key comorbidities, by 
ALRI diagnosis and Northern Territory region: Indigenous infants aged <12 months, 1 January 1999 to 31 December 2004
Gastroenteritis Anaemia Malnutrition
Episodes of care Top End Centre NT Top End Centre NT Top End Centre NT
All ALRI 411 (24.0%) 421 (27.8%) 832 (25.8%) 428 (25.0%) 468 (30.9%) 896 (27.8%) 70 (4.8%) 58 (3.8%) 128 (4.0%)
Bronchiolitis 175 (17.4%) 197 (23.5%) 372 (20.0%) 211 (20.7%) 186 (22.2%) 397 (21.4%) 25 (2.5%) 27 (3.3%) 52 (2.8%)
Pneumonia 168 (30.9%) 189 (32.1%) 357 (31.5%) 182 (33.5%) 241 (40.9%) 423 (37.3%) 28 (5.2%) 29 (4.9%) 57 (5.0%)
Radiologically confirmed 
pneumonia
70 (28.3%) 63 (28.6%) 133 (28.5%) 82 (33.2%) 89 (40.5%) 171 (36.6%) 11 (4.5%) 14 (6.4%) 25 (5.4%)
Influenza 14 (23.3%) 5 (29.4%) 19 (24.7%) 22 (36.7%) 11 (64.7%) 33 (42.9%) 2 (3.3%) 1 (5.9%) 3 (3.9%)
Non-ALRI 962 (11.3%) 817 (19.4%) 1779 (14.0%) 447 (5.3%) 420 (10.0%) 867 (6.8%) 133 (1.6%) 85 (2.0%) 218 (1.7%)
* Percentages are of total ALRI episodes in each diagnosis category and region. ◆588 MJA • Volume 192 Number 10 • 17 May 2010
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ology of pneumonia, independently and as
interrelated agents in bacterial infections.21
The high proportion of infants admitted to
hospital with ALRI and a comorbidity of
anaemia, gastroenteritis and/or malnutrition,
known risk factors for ALRI,22-24 is likely to
be important. However, among studies using
the WHO protocol, there is limited reporting
of these conditions in populations without a
high burden of HIV and malaria. It is unlikely
that comorbidities alone are contributing to
the high rates of disease in Indigenous
infants. Overcrowding, young maternal age,
low birthweight, and exposure to indoor and/
or tobacco smoke are probable contributing
factors. However, there is virtually no
research specifically examining their relative
importance for Indigenous children hospi-
talised with ALRIs. A small survey of 73
hospitalised Aboriginal children aged less
than 14 years in Alice Springs found that the
rate ratio for regular cough in children with
household tobacco exposure was 2.77 (95%
CI, 1.06–7.23).25 The Western Australian
Aboriginal Child Health Survey found that
parent-reported respiratory infections were
more common in low-birthweight babies and
those who had not been breastfed exclusively
for 6 months.26
The differing disease burdens in the Top
End and Central Australian regions of the
NT highlight the problems with reporting
aggregate data across populations and
regions. The difference is difficult to explain
in the absence of any recent data examining
the individual, social, environmental, health
care and/or hospitalisation referral factors
between the regions. The higher proportion
of comorbidities in Central Australian chil-
dren admitted with non-ALRI conditions
suggests that they may have poorer overall
health, but further research is needed to
explain the differences reported here.
The frequency of multiple episodes of
ALRI in early infancy is likely to be the key
factor in the incidence of non-cystic fibrosis
bronchiectasis in this population before 12
months of age. Data on the incidence in
other disadvantaged populations in the
same age group are scarce.
Our data provide no real clues as to the
major aetiological causes of ALRI in
Indigenous infants in the NT. The bulk of
diagnoses are of unspecified aetiology. Our
study also further highlights the limitations
of using hospital discharge diagnoses alone
to examine the epidemiology of disease at
the population level, particularly given the
suboptimal sensitivity for subcategories of
ALRI.27-29 We specifically included all diag-
noses, not just primary diagnosis codes, and
all chest x-rays taken in any admission for
4 ICD-10-AM discharge diagnoses (n=3626) for 3227 hospital episodes of care for acute lower respiratory infection: Northern 
Territory Indigenous infants aged <12 months, by region of residence in the NT, 1 January 1999 to 31 December 2004
ICD-10-AM  =  International classification of diseases, 10th revision, Australian modification. *Lobar pneumonia unspecified (Centre, 3); pneumonia due to staphylococcus 
(Centre, 3); pneumonia in viral disease classed elsewhere (Centre, 2); other viral pneumonia (Centre, 2); chlamydial pneumonia (Top End, 1); pneumonia due to other 
specified organisms (Top End, 1); pneumonia due to Klebsiella pneumoniae  (Top End, 1); pneumonia in bacterial disease classed elsewhere (Top End, 1). ◆
Top End Centre NT
Total (%)
Rate per 1000 
child-years Total (%)
Rate per 1000 
child-years Total (%)
Rate per 1000 
child-years
Bronchiolitis
Acute bronchiolitis unspecified 809 (41.7%) 134.9 732 (43.6%) 292.8 1541 (42.6%) 181.3
Acute bronchiolitis, respiratory syncytial virus 212 (10.9%) 35.3 106 (6.3%) 42.4 318 (8.8%) 37.4
Acute bronchiolitis, other specified organism 41 (2.1%) 6.8 42 (2.5%) 16.8 83 (2.3%) 9.8
Bronchitis
Acute bronchitis specified organism 17 (0.9%) 2.8 5 (0.3%) 2.0 22 (0.6%) 2.6
Acute bronchitis unspecified 7 (0.4%) 1.2 4 (0.2%) 1.6 11 (0.3%) 1.3
Influenza
Influenza, virus identified 63 (3.3%) 10.5 15 (0.9%) 6.0 78 (2.2%) 9.2
Influenza, virus not identified 2 (0.1%) 0.3 6 (0.4%) 2.4 8 (0.2%) 0.9
Pneumonia
Pneumonia unspecified 465 (24.0%) 77.5 541 (32.3%) 216.4 1006 (27.8%) 118.4
Bronchopneumonia unspecified 41 (2.1%) 6.8 32 (1.9%) 12.8 73 (2.0%) 8.6
Respiratory syncytial virus pneumonia 23 (1.2%) 3.8 21 (1.3%) 8.4 44 (1.2%) 5.2
Adenoviral pneumonia 6 (0.3%) 1.0 11 (0.7%) 4.4 17 (0.5%) 2.0
Bacterial pneumonia unspecified 16 (0.8%) 2.7 0 (0.0) 0.0 16 (0.4%) 1.9
Pneumonia due to Haemophilus influenzae 8 (0.4%) 1.3 6 (0.4%) 2.4 14 (0.4%) 1.6
Parainfluenza virus pneumonia 5 (0.3%) 0.8 8 (0.5%) 3.2 13 (0.4%) 1.5
Pneumonia due to Streptococcus pneumoniae 10 (0.5%) 1.7 3 (0.2%) 1.2 13 (0.4%) 1.5
Pneumonia due to other streptococci 10 (0.5%) 1.7 3 (0.2%) 1.2 13 (0.4%) 1.5
Viral pneumonia unspecified 2 (0.1%) 0.3 5 (0.3%) 2.0 7 (0.2%) 0.8
Other pneumonia (n = 14)*
Unspecified acute lower respiratory infection 206 (10.6%) 34.3 129 (7.7%) 51.6 335 (9.3%) 39.4
Total 1947 (100.0%) 323.1 1679 (100.0%) 670.7 3626 (100.0%) 426.7MJA • Volume 192 Number 10 • 17 May 2010 589
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and to account for changes in coding prac-
tices over time. Furthermore, while there are
concerns about the sensitivity and specifi-
city of the WHO radiological definition of
pneumonia,30 in our dataset 8.4% of radio-
logically confirmed cases had no corres-
ponding ALRI diagnosis. Similarly, chest x-
rays were not taken in 12% of infants with
an ALRI diagnosis, and milder cases may
have been missed.
The high rates of ALRIs and bronchiecta-
sis in NT Indigenous infants warrant imme-
diate attention. The Aboriginal health debate
is currently dominated by the burden of the
metabolic syndrome, chronic disease and
substance abuse in adults. However, the
huge burden of childhood ALRI has multi-
ple consequences for the Aboriginal popula-
tion. The response must be multipronged:
research must continue, and policies that
change the living environment and facilitate
hygiene,31 improve educational outcomes
for parents of the future, and enhance
parenting skills32 must be a priority.
ACKNOWLEDGEMENTS
We would like to thank the PICTURE study team:
Alan Ruben, Debbie Taylor-Thomson, Peter Morris,
Grant Mackenzie, Paul Bauert, Gavin Wheaton,
John DeCampo, Margaret DeCampo and Jane
Benson. Kerry-Ann O’Grady is funded by a
National Health and Medical Research Council
(NHMRC) Postdoctoral Training Fellowship in
Indigenous Health.
COMPETING INTERESTS
The study that led to this secondary analysis was
funded by Wyeth Vaccines. Wyeth Vaccines had no
role in the design, data collection, analysis and inter-
pretation of the study, or in the writing of the article.
AUTHOR DETAILS
Kerry-Ann F O’Grady, GDipPH, MAppEpid, 
PhD, NHMRC Post-Doctoral Training Fellow, 
Child Health Division1,2
Paul J Torzillo, AM, MB BS, FRACP, FJFICM, 
Associate Professor, Department of Respiratory 
Medicine3
Anne B Chang, FRACP, MPHTM, PhD, Professor 
and Head, Child Health Division1,4
1 Menzies School of Health Research, Charles 
Darwin University, Darwin, NT.
2 Centre for Clinical Research Excellence in 
Child and Adolescent Immunisation, Menzies 
School of Health Research and University of 
Melbourne, Darwin, NT.
3 Royal Prince Alfred Hospital, Sydney, and 
University of Sydney, Sydney, NSW.
4 Queensland Children’s Respiratory Centre, 
Queensland Children’s Medical Research 
Institute, Royal Children’s Hospital, Brisbane, 
QLD.
Correspondence: k.ogrady@uq.edu.au
REFERENCES
1 Li SQ, Guthridge S, d’Espaignet ET, Paterson B.
From infancy to young adulthood: health status in
the Northern Territory, 2006. Darwin: Northern
Territory Department of Health and Families,
2007.
2 Brenneman G, Rhoades E, Chilton L. Forty years
in partnership: the American Academy of Pediat-
rics and the Indian Health Service. Pediatrics 2006;
118: e1257-e1263.
3 Tennant PW, Gibson GJ, Pearce MS. Lifecourse
predictors of adult respiratory function: results
from the Newcastle Thousand Families Study.
Thorax 2008; 63: 823-830.
4 Dharmage SC, Erbas B, Jarvis D, et al. Do child-
hood respiratory infections continue to influence
adult respiratory morbidity? Eur Respir J 2009; 33:
237-244.
5 Valery PC, Torzillo PJ, Mulholland K, et al. Hospi-
tal-based case-control study of bronchiectasis in
Indigenous children in Central Australia. Pediatr
Infect Dis J 2004; 23: 902-908.
6 Chang AB, Masel JP, Boyce NC, Torzillo PJ. Respi-
ratory morbidity in central Australian Aboriginal
children with alveolar lobar abnormalities. Med J
Aust 2003; 178: 490-494. 
7 O’Grady K, Taylor-Thomson D, Chang AB, et al.
Rates of radiologically confirmed pneumonia as
defined by the World Health Organization in
Northern Territory Indigenous children. Med J
Aust 2010; 192: 592-595.
8 World Health Organization Pneumonia Vaccine
Trial Investigators Group. Standardization of inter-
pretation of chest radiographs for the diagnosis
of pneumonia in children. Geneva: World Health
Organization Department of Vaccines and Bio-
logicals, 2001. http://www.who.int/vaccines-docu-
ments/DocsPDF01/www616.pdf (accessed Mar
2010).
9 Peck AJ, Holman RC, Curns AT, et al. Lower
respiratory tract infections among American
Indian and Alaska Native children and the general
population of US children. Pediatr Infect Dis J
2005; 24: 342-351.
10 Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell
H. Global estimate of the incidence of clinical
pneumonia among children under five years of
age. Bull World Health Organ 2004; 82: 895-903.
11 Hansen J, Black S, Shinefield H, et al. Effective-
ness of heptavalent pneumococcal conjugate
vaccine in children younger than 5 years of age
for prevention of pneumonia: updated analysis
using World Health Organization standardized
interpretation of chest radiographs. Pediatr Infect
Dis J 2006; 25: 779-781.
12 Cutts FT, Zaman SM, Enwere G, et al. Efficacy of
nine-valent pneumococcal conjugate vaccine
against pneumonia and invasive pneumococcal
disease in The Gambia: randomised, double-
blind, placebo-controlled trial. Lancet 2005; 365:
1139-1146.
13 Klugman KP, Madhi SA, Heubner R, et al. A trial of
a 9-valent pneumococcal conjugate vaccine in
children with and those without HIV infection. N
Engl J Med 2003; 349: 1341-1348.
14 Magree HC, Russell FM, Sa’aga R, et al. Chest x-
ray confirmed pneumonia in children in Fiji. Bull
World Health Organ 2005; 83: 427-434.
15 Hortal M, Estevan M, Iraola I, De Mucio B. A
population-based assessment of the disease bur-
den of consolidated pneumonia in hospitalized
children under five years of age. Int J Infect Dis
2007; 11: 273-277.
16 Gessner BD, Sutanto A, Linehan M, et al. Inci-
dences of vaccine-preventable Haemophilus
influenzae type b pneumonia and meningitis in
Indonesian children: hamlet-randomised vaccine-
probe trial. Lancet 2005; 365: 43-52.
17 Lucero MG, Nohynek H, Williams G, et al. Efficacy
of an 11-valent pneumococcal conjugate vaccine
against radiologically confirmed pneumonia
among children less than 2 years of age in the
Philippines: a randomized, double-blind, pla-
cebo-controlled trial. Pediatr Infect Dis J 2009; 28:
455-462.
18 Khan AJ, Hussain H, Omer SB, et al. High inci-
dence of childhood pneumonia at high altitudes
in Pakistan: a longitudinal cohort study. Bull World
Health Organ 2009; 87: 193-199.
19 Bolisetty S, Wheaton G, Chang AB. Respiratory
syncytial virus infection and immunoprophylaxis
for selected high-risk children in Central Australia.
Aust J Rural Health 2005; 13: 265-270.
20 Moore H, Burgner D, Carville K, et al. Diverging
trends for lower respiratory infections in non-
Aboriginal and Aboriginal children. J Paediatr
Child Health 2007; 43: 451-457.
21 Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epide-
miology and etiology of childhood pneumonia.
Bull World Health Organ 2008; 86: 408-416.
22 Schmidt WP, Cairncross S, Barreto ML, et al.
Recent diarrhoeal illness and risk of lower respira-
tory infections in children under the age of 5
years. Int J Epidemiol 2009; 38: 766-772.
23 Caulfield LE, de Onis M, Blossner M, Black RE.
Undernutrition as an underlying cause of child
deaths associated with diarrhea, pneumonia,
malaria, and measles. Am J Clin Nutr 2004; 80:
193-198.
24 Zaman K, Baqui AH, Yunus M, et al. Association
between nutritional status, cell-mediated immune
status and acute lower respiratory infections in
Bangladeshi children. Eur J Clin Nutr 1996; 50:
309-314.
25 Hudson L, White A, Roseby R. Tobacco smoke
exposure in hospitalised Aboriginal children in
Central Australia. J Paediatr Child Health 2009;
45: 224-227.
26 Oddy WH, Kickett-Tucker C, De Maio J, et al. The
association of infant feeding with parent-reported
infections and hospitalisations in the West Aus-
tralian Aboriginal Child Health Survey. Aust N Z J
Public Health 2008; 32: 207-215.
27 Keren R, Wheeler A, Coffin SE, et al. ICD-9 codes
for indentifying influenza hospitalizations in chil-
dren. Emerg Infect Dis 2006; 12: 1603-1604.
28 van de Garde EM, Oosterheert JJ, Bonten M, et
al. International classification of diseases codes
showed modest sensitivity for detecting commu-
nity-acquired pneumonia. J Clin Epidemiol 2007;
60: 834-838.
29 Guevara RE, Butler JC, Marston BJ, et al. Accu-
racy of ICD-9-CM codes in detecting community-
acquired pneumococcal pneumonia for inci-
dence and vaccine efficacy studies. Am J Epide-
miol 1999; 149: 282-289.
30 Madhi SA, Klugman KP. World Health Organisa-
tion definition of “radiologically-confirmed pneu-
monia” may under-estimate the true public
health value of conjugate pneumococcal vac-
cines. Vaccine 2007; 25: 2413-2419.
31 Torzillo PJ, Pholeros P, Rainow S, et al. The state of
health hardware in Aboriginal communities in
rural and remote Australia. Aust N Z J Public
Health 2008; 32: 7-11.
32 Olds DL, Kitzman H, Hanks C, et al. Effects of
nurse home visiting on maternal and child func-
tioning: age-9 follow-up of a randomized trial.
Pediatrics 2007; 120: e832-e845.
(Received 21 Jun 2009, accepted 27 Oct 2009) ❏590 MJA • Volume 192 Number 10 • 17 May 2010
